Core Viewpoint - Lumentum has reported strong financial results for Q2, exceeding expectations in key metrics and securing significant orders in the CPO market, although its stock price reflects optimistic future earnings projections [3][4][13]. Financial Performance - Lumentum's Q2 non-GAAP revenue reached $665.5 million, with earnings per share (EPS) of $1.67, surpassing Morgan Stanley's expectations of $648.6 million and $1.38 respectively [4]. - The non-GAAP gross margin was 42.5%, exceeding the expected 38.6% by 385 basis points, driven by product mix improvement and successful price increases [3][4]. - The non-GAAP operating margin reached 25.2%, significantly above the expected 20.6%, showcasing the company's ability to enhance revenue and margins in a strong demand environment [5]. Business Developments - Lumentum has secured a multi-hundred million dollar order for CPO expansion, expected to ship in the second half of 2027, marking a significant milestone in the commercialization of CPO [6][7]. - The OCS business has over $400 million in backlog orders, with expectations to reach a quarterly revenue scale of $100 million two quarters earlier than previously anticipated [6][7]. Market Dynamics - Despite increasing production capacity by 20% in December, supply shortages persist, granting Lumentum strong pricing power [8]. - The demand for 1.6T optical modules is primarily directed towards EML lasers, indicating EML's dominance in the next-generation high-speed module competition [8]. Valuation Insights - Morgan Stanley raised Lumentum's target price from $350 to $420, based on a projected EPS of $15 for calendar year 2027, reflecting a 28x price-to-earnings ratio [10]. - The stock price has increased by 30% since the earnings report, leading Morgan Stanley to maintain an "Equal-weight" rating, as the current valuation already incorporates aggressive earnings expectations [13].